医学
危险系数
内科学
置信区间
比例危险模型
结直肠癌
胃肠病学
转移
克拉斯
临床终点
逻辑回归
肿瘤科
外科
癌症
随机对照试验
作者
Fawaz Jade,Marc Pocard,Gabriel Liberale,Clarisse Eveno,M. Brice,Samantha Lucas,H. Martin,Sarah Charles,Olivia Sgarbură,Abdelkader Taïbi,Helen Christian
摘要
Abstract Background In patients at high risk of peritoneal metastasis (PM) recurrence following surgical treatment of colon cancer (CC), second‐look laparoscopic exploration (SLLE) is mandatory; however, the best timing is unknown. We created a tool to refine the timing of early SLLE in patients at high risk of PM recurrence. Methods This international cohort study included patients who underwent CC surgery between 2009 and 2020. All patients had PM recurrence. Factors associated with PM‐free survival (PMFS) were assessed using Cox regression. The primary endpoint was early PM recurrence defined as a PMFS of <6 months. A model (logistic regression) was fitted and corrected using bootstrap. Results In total, 235 patients were included. The median PMFS was 13 (IQR, 8–22) months, and 15.7% of the patients experienced an early PM recurrence. Synchronous limited PM and/or ovarian metastasis (hazard ratio [HR]: 2.50; 95% confidence interval [CI]: [1.66–3.78]; p < 0.001) were associated with a very high‐risk status requiring SLLE. T4 (HR: 1.47; 95% CI: [1.03–2.11]; p = 0.036), transverse tumor localization (HR: 0.35; 95% CI: [0.17–0.69]; p = 0.002), emergency surgery (HR: 2.06; 95% CI: [1.36–3.13]; p < 0.001), mucinous subtype (HR: 0.50; 95% CI [0.30, 0.82]; p = 0.006), microsatellite instability (HR: 2.29; 95% CI [1.06, 4.93]; p = 0.036), KRAS mutation (HR: 1.78; 95% CI: [1.24–2.55]; p = 0.002), and complete protocol of adjuvant chemotherapy (HR: 0.93; 95% CI: [0.89–0.96]; p < 0.001) were also prognostic factors for PMFS. Thus, a model was fitted (area under the curve: 0.87; 95% CI: [0.82–0.92]) for prediction, and a cutoff of 150 points was identified to classify patients at high risk of early PM recurrence. Conclusion Using a nomogram, eight prognostic factors were identified to select patients at high risk for early PM recurrence objectively. Patients reaching 150 points could benefit from an early SLLE.
科研通智能强力驱动
Strongly Powered by AbleSci AI